The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,703,020 in first-year total cost, median $2,900,000.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (01)]2
- Special Emphasis Panel[ZEY1 VSN (06)]1
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- UNIVERSITY OF WISCONSIN-MADISON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Surgical IIH Treatment Trial1U10EY025990-01A1 | KUPERSMITH, MARK J | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $3,426,258 | ZEY1 |
| 2016 | Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus1U10EY026869-01 | COHEN, ELISABETH JGOLDBERG, JUDITH D.HOCHMAN, JUDITH S | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,900,000 | ZEY1 |
| 2015 | Epidemiology of Age-related Macular Degeneration and Other Retinal Diseases2U10EY006594-26A1 | KLEIN, RONALD | UNIVERSITY OF WISCONSIN-MADISON, WI | $1,376,762 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.